{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T08:15:24Z","timestamp":1770538524276,"version":"3.49.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,11,16]],"date-time":"2018-11-16T00:00:00Z","timestamp":1542326400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,11,16]],"date-time":"2018-11-16T00:00:00Z","timestamp":1542326400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"the Japanese Ministry of Health, Labor, and Welfare"},{"DOI":"10.13039\/501100001700","name":"the Japanese Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s12185-018-2561-9","type":"journal-article","created":{"date-parts":[[2018,11,16]],"date-time":"2018-11-16T07:41:38Z","timestamp":1542354098000},"page":"214-220","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["A high titer of acquired factor V inhibitor in a hemodialysis patient who developed arterial thrombosis"],"prefix":"10.1007","volume":"109","author":[{"given":"Hina","family":"Ogawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayoshi","family":"Souri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunori","family":"Kanouchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsukasa","family":"Osaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rie","family":"Ohkubo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Kawanishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachiko","family":"Wakai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keita","family":"Morikane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akitada","family":"Ichinose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,11,16]]},"reference":[{"key":"2561_CR1","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1046\/j.1468-0734.2001.00049.x","volume":"5","author":"LN Boggio","year":"2001","unstructured":"Boggio LN, Green D. Acquired hemophilia. Rev Clin Exp Hematol. 2001;5:389\u2013404.","journal-title":"Rev Clin Exp Hematol"},{"key":"2561_CR2","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1182\/blood-2006-06-029850","volume":"109","author":"PW Collins","year":"2007","unstructured":"Collins PW, Hirsch S, Baglin TP, Dolan G, Hanley J, Makris M, et al. Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors\u2019 Organisation. Blood. 2007;109:1870\u20137.","journal-title":"Blood"},{"key":"2561_CR3","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1097\/00001721-200412000-00003","volume":"8","author":"EJ Favaloro","year":"2004","unstructured":"Favaloro EJ. Posen J. Ramakrishna R. Solatani S. McRae S. Just S, et al. Factor V inhibitors: rare or not so uncommon? A multi-laboratory investigation. Blood Coagul Fibrinolysis. 2004;8:637\u201347.","journal-title":"Blood Coagul Fibrinolysis"},{"key":"2561_CR4","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1160\/TH08-11-0767","volume":"101","author":"A Ang","year":"2009","unstructured":"Ang A. Kuperan P. Ng C. Ng HJ. Acquired factor V inhibitor. A problem-based systematic review. J Thromb Haemost. 2009;101:852\u20139.","journal-title":"J Thromb Haemost"},{"key":"2561_CR5","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.5858\/arpa.2016-0445-RS","volume":"141","author":"NJ Olson","year":"2017","unstructured":"Olson NJ, Ornstein DL. Factor V, Inhibitors. A diagnostic and therapeutic challenge. Arch Pathol Lab Med. 2017;141:1728\u201331.","journal-title":"Arch Pathol Lab Med"},{"key":"2561_CR6","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/S0022-2143(99)90062-8","volume":"133","author":"TL Ortel","year":"1999","unstructured":"Ortel TL. Clinical and laboratory manifestations of anti-factor V antibodies. J Lab Clin Med. 1999;133:326\u201334.","journal-title":"J Lab Clin Med"},{"key":"2561_CR7","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S0950-3536(98)80050-4","volume":"11","author":"P Knobl","year":"1998","unstructured":"Knobl P, Lechner K. Acquired factor V inhibitors. Bailli\u00e8res Clin Haematol. 1998;11:305\u20138.","journal-title":"Bailli\u00e8res Clin Haematol"},{"key":"2561_CR8","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.1182\/blood.V91.11.4188","volume":"91","author":"TL Ortel","year":"1998","unstructured":"Ortel TL, Moore KD, Quinn-Allen MA, Okamura T, Sinclair AJ, Lazarchick J, et al. Inhibitory anti-factor V antibodies bind to the factor V C2 domain and are associated with hemorrhagic manifestations. Blood. 1998;91:4188\u201396.","journal-title":"Blood"},{"issue":"2","key":"2561_CR9","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s12185-018-2453-z","volume":"108","author":"Y Kadohira","year":"2018","unstructured":"Kadohira Y, Yamada S, Hayashi T, Morishita E, Asakura H, Ichinose A. A discrepancy between prothrombin time and Normotest (Hepaplastintest) results is useful for diagnosis of acquired factor V inhibitors. Int J Hematol. 2018;108(2):145\u201350.","journal-title":"Int J Hematol"},{"key":"2561_CR10","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1182\/blood.V60.1.59.59","volume":"60","author":"PB Tracy","year":"1982","unstructured":"Tracy PB, Eide LL, Bowie EJ, Mann KG. Radioimmunoassay of factor V in human plasma and platelets. Blood. 1982;60:59\u201363.","journal-title":"Blood"},{"key":"2561_CR11","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1002\/ajh.2830420410","volume":"42","author":"A Kapur","year":"1993","unstructured":"Kapur A, Kelsey PR, Isaacs PE. Factor V inhibitor in thrombosis. Am J Hematol. 1993;42:384\u20138.","journal-title":"Am J Hematol"},{"key":"2561_CR12","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1111\/j.1365-2141.1995.tb08430.x","volume":"89","author":"T Koyama","year":"1995","unstructured":"Koyama T, Saito T, Kusano T, Hirosawa S. Factor V inhibitor associated with Sj\u00f6gren\u2019s syndrome. Br J Haematol. 1995;89:893\u20136.","journal-title":"Br J Haematol"},{"key":"2561_CR13","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/ajh.2830490122","volume":"49","author":"S George","year":"1995","unstructured":"George S, Nagabhushana MS, Cyran EM. Coagulopathy due to an acquired factor V inhibitor and subsequently thrombosis. Am J Hematol. 1995;49:98\u2013100.","journal-title":"Am J Hematol"},{"key":"2561_CR14","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1002\/(SICI)1096-8652(199802)57:2<176::AID-AJH14>3.0.CO;2-A","volume":"57","author":"PW Kamphuisen","year":"1998","unstructured":"Kamphuisen PW, Haan J, Rosekrans PC, Van Der Meer FJ. Deep-vein thrombosis and coumarin skin necrosis associated with a factor V inhibitor with lupus-like features. Am J Hematol. 1998;57:176\u20138.","journal-title":"Am J Hematol"},{"key":"2561_CR15","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1007\/s00277-012-1485-3","volume":"91","author":"T Higuchi","year":"2012","unstructured":"Higuchi T, Okamoto T, Kou T, Takeuchi T, Koyamada R, Okada S. Deep vein thrombosis associated with factor V inhibitor followed by immune thrombocytopenia. Ann Hematol. 2012;91:1831\u20132.","journal-title":"Ann Hematol"},{"key":"2561_CR16","doi-asserted-by":"publisher","first-page":"27","DOI":"10.2147\/IMCRJ.S59236","volume":"7","author":"NI Aljohani","year":"2014","unstructured":"Aljohani NI, Matthews JH. Acquired factor V inhibitor in a patient with mantle cell lymphoma presenting with hematuria followed by thrombosis: a case report. Int Med Case Rep J. 2014;7:27\u201330.","journal-title":"Int Med Case Rep J"},{"key":"2561_CR17","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1111\/jth.13114","volume":"13","author":"K Donohoe","year":"2015","unstructured":"Donohoe K, Levine R. Acquired factor V inhibitor after exposure to topical human thrombin related to an otorhinolaryngological procedure. J Thromb Haemost. 2015;13:1787\u20139.","journal-title":"J Thromb Haemost"},{"key":"2561_CR18","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1111\/trf.13623","volume":"56","author":"C Gavva","year":"2016","unstructured":"Gavva C, Yates SG, Rambally S, Sarode R. Transfusion management of factor V deficiency: three case reports and review of the literature. Transfusion. 2016;56:1745\u20139.","journal-title":"Transfusion"},{"key":"2561_CR19","doi-asserted-by":"publisher","first-page":"e269-71","DOI":"10.1515\/cclm-2015-1103","volume":"54","author":"P Rief","year":"2016","unstructured":"Rief P, Hackl G, Hafner F, Raggam RB, W\u00f6lfler A, Brodmann M, et al. Venous thromboembolism in a patient with persistent inhibitor to coagulation factor V\u2014a case report. Clin Chem Lab Med. 2016;54:e269-71.","journal-title":"Clin Chem Lab Med"},{"key":"2561_CR20","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1111\/jth.13665","volume":"15","author":"B Dahlb\u00e4ck","year":"2017","unstructured":"Dahlb\u00e4ck B. Novel insights into the regulation of coagulation by factor V isoforms, tissue factor pathway inhibitor\u03b1, and protein S. J Thromb Haemost. 2017;15:1241\u201350.","journal-title":"J Thromb Haemost"},{"key":"2561_CR21","doi-asserted-by":"publisher","first-page":"3985","DOI":"10.1182\/blood.V99.11.3985","volume":"99","author":"M Kalafatis","year":"2002","unstructured":"Kalafatis M, Simioni P, Tormene D, Beck DO, Luni S, Girolami A. Isolation and characterization of an antifactor V antibody causing activated protein C resistance from a patient with severe thrombotic manifestations. Blood. 2002;99:3985\u201392.","journal-title":"Blood"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-018-2561-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-018-2561-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-018-2561-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T09:58:02Z","timestamp":1589450282000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-018-2561-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,16]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["2561"],"URL":"https:\/\/doi.org\/10.1007\/s12185-018-2561-9","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,16]]},"assertion":[{"value":"3 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflicts of interests in association with this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}